000 02106na a2200253 4500
999 _c6740
_d6740
003 PC6740
005 20180913113453.0
008 130622s2013 xxx||||| |||| 00| 0 eng d
040 _cH12O
041 _aspa
100 _aRodríguez Antolín, Alfredo
_91692
_eUrología
245 0 0 _aRegistro nacional de cáncer de próstata 2010 en España.
_h[artículo]
260 _bActas Urológicas Españolas,
_c2013
300 _a37(1):12-9
500 _aFormato Vancouver: Cózar JM, Miñana B, Gómez-Veiga F, Rodríguez-Antolín A, Villavicencio H, Cantalapiedra A et al. Actas Urol Esp. 2013 Jan;37(1):12-9.
501 _aPMID: 23102541
504 _aContiene 24 referencias
520 _aTo estimate the 2010 incidence of PCa in Spain and describe the clinical profile of newly-diagnosed cases using a nationwide hospital-based registry. Material and methods: National epidemiological study in 25 public hospitals with a specific reference population according to the National Health System. Sociodemographic and clinical variables of all newly diagnosed, histopathological confirmed PCa cases were collected in 2010, in the area of influence of each centre. The age-standardised PCa incidence was determined based on the age distribution of the Spanish population in Spain and in 3 regions: Andalusia, Catalonia and Region of Madrid. Results: 4,087 new cases of PCa were diagnosed for a reference population of 4,933,940 men (21.8% of the Spanish male population). The estimated age-standardised PCa incidence was 82.27 cases per 100,000 men in Spain, 70,38 in Andalusia, 85,70 in Catalonia and 92,29 in the Region of Madrid. Mean age at diagnosis was 69 years. Median PSA was 8 ng/ml. Gleason score was <= 6 in 56.5%, 7 in 26.7% and > 7 in 16.8% of patients. At diagnosis, 90% had localised disease. Conclusions: In the 3 Regions analyzed, around 80-90% of the cases are diagnosed in a clinical localised stage. The incidence rates in Andalusia, Catalonia and Region of Madrid show a great difference between them due to several factors.
710 _9220
_aServicio de Urología
856 _uhttp://pc-h12o-es.m-hdoct.a17.csinet.es/pdf/pc/6/pc6740.pdf
_ySolicitar documento
942 _n0
_2ddc
_cART